Company intelligence / Profile preview
T-Cure Bioscience, Inc.
Sherman Oaks, California, United Statest-cure.com ↗
- Ownership
- Private
- Employees
- ~14
- Development stage
- Phase 1
01
Overview
T-Cure is a clinical-stage immuno-oncology company developing next-generation autologous TCR-T therapies for solid tumors. Its lead program targeting KK-LC‑1 is in Phase 1 trials, with additional candidates against HERV-E and NY‑ESO‑1 in preclinical or early clinical stages. The company’s therapies are designed to address cancers with significant unmet needs by engineering patient-derived immune cells to target novel tumor antigens. Early results include the initiation of first-in-human studies and licensing/partnerships for further development.[5][6][8]
- Therapeutic areas
- Oncology
- Modalities
- Autologous cell therapyTCR-T (T cell receptor-engineered T cells)
- Industry
- Biotech
02
Drug pipeline
8 assets7 more assets in the full pipeline.
03
Partnerships
National Cancer Institute (NCI) – exclusive worldwide license on KK-LC‐1 program and CRADA collaboration on new targets/platforms [7]Rutgers Cancer Institute – clinical research agreement for first-in-human trial of KK-LC‐1 program [6]Immunotech Biopharm Ltd – license agreement to develop/commercialize HERV-E targeted therapy (“800TCR”) in China [8]Atlas Antibodies AB – collaboration on monoclonal antibody development against CT83/KK-LC‐1 [10]
Beyond the preview
Go deeper on T-Cure Bioscience, Inc..
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on T-Cure Bioscience, Inc..